ALK-positive large B-cell lymphoma (Q39094): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: C83.3 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 04:24, 13 August 2026
A usually aggressive large B-cell lymphoma characterised by the presence of monomorphic immunoblast-like neoplastic B-lymphocytes in a sinusoidal growth pattern. The neoplastic B-lymphocytes express the ALK kinase but they lack the 2;5 translocation.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2A81.8 |
||
| English | ALK-positive large B-cell lymphoma |
A usually aggressive large B-cell lymphoma characterised by the presence of monomorphic immunoblast-like neoplastic B-lymphocytes in a sinusoidal growth pattern. The neoplastic B-lymphocytes express the ALK kinase but they lack the 2;5 translocation. |
Statements
CID11:2A81.8
0 references
dki-india-2A81.8
0 references
Concluído
0 references
13 August 2026
0 references
